Dr Peter Ganly

2024

Journal - Research Article

Brown, J. R., Eichhorst, B., Hillmen, P., Jurczak, W., Kaźmierczak, M., Lamanna, N., … Ganly, P. S., Weinkove, R., … Shadman, M. (2024). Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after trreatment. Future Oncology, 20(12), 717-726. doi: 10.2217/fon-2023-0849

Brown, J. R., Eichhorst, B., Lamanna, N., O'Brien, S., Tam, C. S., Qiu, L., … Ganly, P. S., Weinkove, R., … Shadman, M. (2024). Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: Final comparative analysis of ALPINE. Blood. Advance online publication. doi: 10.1182/blood.2024024667

Hungria, V., Robak, P., Hus, M., Zherebtsova, V., Ward, C., Ho, P. J., … Ganly, P., … for the DREAMM-7 Investigators, including George, A. (2024). Belantamab mofodotin, bortezomib, and dexamethasone for multiple myeloma. New England Journal of Medicine, 391(5), 393-407. doi: 10.1056/NEJMoa2405090

2023

Journal - Research Article

Zinzani, P. L., Mayer, J., Flowers, C. R., Bijou, F., De Oliveira, A. C., Song, Y., … Ganly, P., … Trotman, J. (2023). ROSEWOOD: A phase II randomized study of zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy in patients with relapsed or refractory follicular lymphoma. Journal of Clinical Oncology, 41(33), 5107-5117. doi: 10.1200/JCO.23.00775

Hillmen, P., Eichhorst, B., Brown, J. R., Lamanna, N., O'Brien, S. M., Tam, C. S., … Ganly, P. S., Weinkove, R., … Jurczak, W. (2023). Zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: Interim analysis of a randomised phase III trial. Journal of Clinical Oncology, 41(5), 1035-1045. doi: 10.1200/JCO.22.00510

Brown, J. R., Eichhorst, B., Hillmen, P., Jurczak, W., Kaźmierczak, M., Lamanna, N., … Ganly, P. S., Weinkove, R., … Shadman, M. (2023). Zanubrutinib or ibrutinib in relapsed or refractory chronic lymphocytic leukemia. New England Journal of Medicine, 388, 319-332. doi: 10.1056/NEJMoa2211582

2022

Conference Contribution - Published proceedings: Abstract

Brown, J. R., Hillmen, P., Eichhorst, B., Lamanna, N., O'Brien, S., Tam, C., … Ganly, P. S., … Jurczak, W. (2022). First interim analysis of ALPINE Study: Results of a phase 3 randomized study of Zanubrutinib vs Ibrutinib in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Clinical Lymphoma & Myeloma, 22(Suppl. 2), (pp. S266). doi: 10.1016/S2152-2650(22)01324-6

2021

Journal - Research Article

Tam, C. S., Robak, T., Ghia, P., Kahl, B. S., Walker, P., Janowski, W., … Ganly, P. S., … Brown, J. R. (2021). Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion. Haematologica, 106(9), 2354-2363. doi: 10.3324/haematol.2020.259432

Richardson, P. G., Kumar, S. K., Masszi, T., Grzasko, N., Bahlis, N. J., Hansson, M., … Ganly, P., … Moreau, P. (2021). Final overall survival analysis of the TOURMALINE-MM1 phase III trial of ixazomib, lenalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma. Journal of Clinical Oncology, 39(22), 2430-2442. doi: 10.1200/JCO.21.00972

2020

Journal - Research Article

Di Bacco, A., Bahlis, N. J., Munshi, N. C., Avet-Loiseau, H., Masszi, T., Viterbo, L., … Ganly, P., … Moreau, P. (2020). c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma. European Journal of Haematology, 105(1), 35-46. doi: 10.1111/ejh.13405

Conference Contribution - Published proceedings: Abstract

Brown, J. R., Robak, T., Ghia, P., Kahl, B. S., Walker, P., Janowski, W., … Ganly, P. S., … Tam, C. S. (2020). Efficacy and safety of zanubrutinib in patients with Treatment-Naïve (TN) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) with del(17p): Follow-up results from Arm C of the SEQUOIA (BGB-3111-304) trial. Blood, 136(Suppl. 1), (pp. 11-12). doi: 10.1182/blood-2020-134280

2019

Journal - Research Article

Hock, B. D., Mulholland, K. S., Ganly, P., McKenzie, J. L., Pearson, J. F., & MacPherson, S. A. (2019). Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centre. Internal Medicine Journal, 49, 598-606. doi: 10.1111/imj.14155

2018

Journal - Research Article

Mascarenhas, J., Virtgaym, E., Stal, M., Blacklock, H., Gerds, A. T., Mesa, R., Ganly, P., … Moshier, E. (2018). Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: A sponsor-independent international study. Annals of Hematology, 97(8), 1369-1374. doi: 10.1007/s00277-018-3309-6

2017

Journal - Research Article

Mesa, R. A., Vannucchi, A. M., Mead, A., Egyed, M., Szoke, A., Suvorov, A., … Ganly, P., … Harrison, C. N. (2017). Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): An international, randomised, phase 3 trial. Lancet Haematology, 4(5), e225-e236. doi: 10.1016/S2352-3026(17)30027-3

Avet-Loiseau, H., Bahlis, N. J., Chng, W.-J., Masszi, T., Viterbo, L., Pour, L., Ganly, P., … Richardson, P. G. (2017). Ixazomib significantly prolongs progression-free survival in high-rick relapse/refractory myeloma patients. Blood, 130(24), 2610-2618. doi: 10.1182/blood-2017-06-791228

Grigg, A., Butcher, B., Khodr, B., Bajel, A., Hertzberg, M., Patil, S., D'Souza, A., Ganly, P., … on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG). (2017). An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: Results of a phase II prospective trial. Bone Marrow Transplantation, 52, 1288-1293. doi: 10.1038/bmt.2017.108

Gerstung, M., Papaemmanuil, E., Martincorena, I., Bullinger, L., Gaidzik, V. I., Paschka, P., … Ganly, P., … Campbell, P. J. (2017). Precision oncology for acute myeloid leukemia using a knowledge bank approach. Nature Genetics, 49, 332-340. doi: 10.1038/ng.3756

2016

Journal - Research Article

Moreau, P., Masszi, T., Grzasko, N., Bahlis, N. J., Hansson, M., Pour, L., … Ganly, P., … for the TOURMALINE-MM1 Study Group. (2016). Oral ixazomib, lenalidomide, and dexamethasone for multiple myeloma. New England Journal of Medicine, 374, 1621-1634. doi: 10.1056/NEJMoa1516282

Bolli, N., Li, Y., Sathiaseelan, V., Raine, K., Jones, D., Ganly, P., … Munshi, N. C. (2016). A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma. Blood Cancer Journal, 6(9), e467. doi: 10.1038/bcj.2016.72

Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., … Ganly, P., … Campbell, P. J. (2016). Genomic classification and prognosis in acute myeloid leukemia. New England Journal of Medicine, 374(23), 2209-2221. doi: 10.1056/NEJMoa1516192

2015

Journal - Research Article

Mant, S., Taylor, G., Dutton, D., Butler, A., Browett, P., & Ganly, P. (2015). Development of T-cell lymphomas with an activated cytotoxic immunophenotype, including anaplastic large cell lymphomas, in patients with chronic leukemia: A series of six cases. Leukemia & Lymphoma, 56(3), 774-778. doi: 10.3109/10428194.2014.927460

Conference Contribution - Published proceedings: Abstract

Perkins, A., Mesa, R., Harrison, C., Egyed, M., Mead, A., Suvorov, A., … Ganly, P., … Vannucchi, A. (2015). PERSIST-1 phase III study of pacritinib (Pac) versus best available therapy (BAT) in primary or secondary myelofibrosis (MF). Proceedings of the Haematology Society of Australia and New Zealand, the Australian & New Zealand Society of Blood Transfusion and the Australasian Society of Thrombosis and Haemostasis (HAA) Annual Scientific Meeting. 043. Retrieved from http://www.haa2015.com/

2014

Journal - Research Article

Ganly, P., Cole, S., Trengrove, A., & Butler, A. (2014). Outcomes of allogeneic haematopoietic stem cell transplants at a small New Zealand centre: Does size matter? Internal Medicine Journal, 44(7), 683-689. doi: 10.1111/imj.12456

2013

Journal - Research Article

Fernyhough, L. J., Hock, B. D., Taylor, J., Pearson, J., & Ganly, P. (2013). Survival of myeloma patients following the introduction of thalidomide as a second-line therapy: A retrospective study at a single New Zealand centre. Internal Medicine Journal, 43(2), 130-137. doi: 10.1111/j.1445-5994.2012.02819.x

2012

Conference Contribution - Published proceedings: Abstract

Ganly, P. (2012). Evolution, revolution, science changing life (CML). New Zealand Journal of Medical Laboratory Science, 66(3), (pp. 84). [Abstract]

2011

Journal - Research Article

Nivison-Smith, I., Dodds, A. J., Doocey, R., Ganly, P., Gibson, J., Ma, D. D. F., … Bradstock, K. F. (2011). Allogeneic haemopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: Factors associated with improved survival outcome. Leukemia & Lymphoma, 52(9), 1727-1735. doi: 10.3109/10428194.2011.582201

Journal - Research Other

Ganly, P., Downing, J., Stiven, P., Frizelle, F., & Badami, K. (2011). Clinical and serological diagnoses of a patient with vancomycin-induced thrombocytopenia [Letter to the editor]. Transfusion Medicine, 21(2), 137-139. doi: 10.1111/j.1365-3148.2010.01052.x

Conference Contribution - Published proceedings: Abstract

Taylor, J., Fernyhough, L., Hock, B., & Ganly, P. (2011). Multiple myeloma patients treated in Christchurch, New Zealand: A retrospective analysis. Proceedings of the Inaugural International Cancer Symposium. Retrieved from http://www.wnmeds.ac.nz/cancersymposium/programme.html

2010

Journal - Research Article

Kim, D.-W., Banavali, S. D., Bunworasate, U., Goh, Y.-T., Ganly, P., Huang, H., … Wong, R. (2010). Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy group. Leukemia Research, 34(11), 1459-1471. doi: 10.1016/j.leukres.2010.03.033

Robak, T., Dmoszynska, A., Solal-Céligny, P., Warzocha, K., Loscertales, J., . . ., Ganly, P. S., & et al (2010). Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia. Journal of Clinical Oncology, 28(10), 1756-1765. doi: 10.1200/JCO.2009.26.4556

2009

Journal - Research Article

Hernandez, E., Ganly, P., Charu, V., DiBenedetto, J., Tomita, D., Lillie, T., … ARANESP 20030232 Study Group. (2009). Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia. Current Medical Research & Opinion, 25(9), 2109-2120. doi: 10.1185/03007990903084164

Marr, H., McDonald, E.-J., Merriman, E., Smith, M., Mangos, H., Stoddart, C., & Ganly, P. (2009). Successful treatment of transplant-associated microangiopathy with rituximab [Clinical correspondence]. New Zealand Medical Journal, 122(1292). Retrieved from http://journal.nzma.org.nz/journal/122-1292/3534/content.pdf

Conference Contribution - Published proceedings: Abstract

Benjes, S., Ganly, P., Spearing, R., & Morris, C. (2009). Complex BCR-ABL1 gene rearrangements in chronic myeloid leukaemia. Chromosome Research. 17(Suppl. 1), (pp. S153). doi: 10.1007/s10577-009-9043-0

Conference Contribution - Poster Presentation (not in published proceedings)

Benjes, S., Ganly, P., Spearing, R., & Morris, C. (2009, July). Complex BCR-ABL1 gene rearrangements in chronic myeloid leukaemia. Poster session presented at the 7th European Cytogenetics Conference, Stockholm, Sweden.

2008

Journal - Research Article

Sanders, J., Pithie, A., Ganly, P., Surgenor, L., Wilson, R., Merriman, E., … Chambers, S. (2008). A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. Journal of Antimicrobial Chemotherapy, 62(4), 809-815. doi: 10.1093/jac/dkn284

Ganly, P. S., Keeman, H., Spearing, R. L., Smith, M. P., Patton, N., Merriman, E. G., & Gibbons, S. S. (2008). Written advice can provide a safe and acceptable alternative to new patient assessment for selected referrals to haematologists. Medical Journal of Australia, 188(1), 9-12.

Journal - Research Other

Ganly, P., Saleem, M., Marr, H., Burt, M., Florkowski, C., & Williamson, A. (2008). Not walking or communicating: Is all well? [Case report]. Lancet, 372(9655), 2086. doi: 10.1016/S0140-6736(08)61870-X

Conference Contribution - Published proceedings: Abstract

Schonegevel, L., Butler, A., Patton, N., Spearing, R. L., & Ganly, P. (2008). Acquisition and loss of the Janus kinase 2 V617F mutation post allogeneic transplantation. Bone Marrow Transplantation. 41(Suppl. 1), (pp. S196). doi: 10.1038/bmt.2008.31

Conference Contribution - Verbal presentation and other Conference outputs

Moon, S.-Y., McKenzie, J., Jewell, U., Ganly, P., & Morris, C. (2008, August-September). Identification of novel CNVs in chronic lymphocytic leukaemia using array CGH. Verbal presentation at the Queenstown Molecular Biology Meetings, Queenstown, New Zealand.

2007

Journal - Research Article

Ganly, P., Hanrahan, V., Baker, B., & Romeril, K. (2007). Identification of JAK2^V617F in patients with polycythemia is highly correlated with conventional criteria for diagnosis of polycythemia vera. American Journal of Hematology, 82, 80-82.

Conference Contribution - Published proceedings: Abstract

Marr, H., Merriman, E., McDonald, E. J., Smith, M., & Ganly, P. (2007). Successful treatment of transplant associated microangiopathy with rituximab. Proceedings of the Haematology Society of Australia and New Zealand Australian and New Zealand Society of Blood Transfusion and Australasian Society of Thrombosis and Haemostasis Annual Scientific Meeting. (pp. A275). Retrieved from http://www.fcconventions.com.au/HAA2007/posters.pdf

Gough, S. M., Aitchison, A., Ganly, P., Spearing, R., & Morris, C. M. (2007). Hs.568769 is disrupted by a novel t(5;10) in acute lymphoblastic leukemia (ALL) and may be an alternate transcript of the 3'overlapping DNTT(TdT) gene. Proceedings of the American Association for Cancer Research (AACR) 98th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/

Moon, S., McKenzie, J., Jewell, U., Ganly, P., & Morris, C. (2007). High-resolution genomic profiling of chronic lymphocytic leukaemia by array CGH. Chromosome Research. 15(Suppl. 1), (pp. 268). [Abstract]

Ganly, P., Keeman, H., Smith, M., Patton, W. N., Spearing, R. L., & Gibbons, S. (2007). Can written advice provide a safe and acceptable alternative to a new patient assessment for selected referrals to haematology. Haematologica. 92(Suppl. 1), (pp. 222). [Abstract]

Conference Contribution - Poster Presentation (not in published proceedings)

Gough, S., Jewell, U., Aitchison, A., Ganly, P., & Morris, C. (2007, August). A novel gene and TdT(DNTT) in acute lymphoblastic leukemia (ALL). Poster session presented at the 17th Queenstown Molecular Biology Meeting, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Moon, S., McKenzie, J., Jewell, U., Ganly, P., & Morris, C. (2007, July). High-resolution genomic profiling of chronic lymphocytic leukaemia by array CGH. Verbal presentation at the 6th European Cytogenetics Conference (ECC), Istanbul, Turkey.

Sanders, J., Pithie, A., Ganly, P., Wilson, R., Merriman, E., Loudon, G., … Chambers, S. (2007, May). A prospective double blind randomised trial comparing intraluminal ethanol with heparinised saline for the prevention of catheter related bacteraemia in immunosuppressed haematology patients. Verbal presentation at the Haematology Society of Australia and New Zealand and New Zealand Flow Cytometry Group Annual New Zealand Branch Meeting, Christchurch, New Zealand.

2006

Journal - Research Article

Ganly, P., & Spearing, R. (2006). Treatment with intravenous immunoglobulin is not a panacea but should be limited to those who can benefit [Editorial]. New Zealand Medical Journal, 119(1246). Retrieved from http://journal.nzma.org.nz/journal/119-1246/2335/content.pdf

Gough, S. M., Benjes, S. M., McDonald, M., Heaton, D., Ganly, P., & Morris, C. M. (2006). Translocation (5;10)(q22;q24) in a case of acute lymphoblastic leukemia. Cancer Genetics & Cytogenetics, 165, 36-40. doi: 10.1016/j.cancergencyto.2005.08.008

Conference Contribution - Published proceedings: Abstract

Merriman, E., Patton, N., Fernyhough, L., & Ganly, P. (2006). Two cases of granulocytic sarcoma. Proceedings of the Haematology Society of Australia & New Zealand (HSANZ) Annual Scientific Meeting. Retrieved from http://www.hsanz.org.au/resources/abstracts.cfm

Ganly, P. (2006). The identification of JAK2V617F in patients with polycythaemia is highly correlated with conventional criteria for diagnosis of polycythaemia vera. Haematologica. 91(S1), (pp. 20). [Abstract]

Gough, S. M., Ganly, P., Spearing, R., & Morris, C. (2006). Hs.568769 and DNTT (TdT): 'Partners in crime' in a novel t(5;10) translocation in ALL? Proceedings of the 11th International Congress of Human Genetics. Retrieved from http://www.ichg2006.com/abstract/770.htm

Moon, S. Y., McKenzie, J., Walker, L., McDonald, M., Ganly, P., & Morris, C. M. (2006). High throughput screening of genomic copy number changes in chronic lymphocytic leukaemia using array comparative genomic hybridisation. In L. Griffiths (Ed.), Proceedings of the 11th International Congress of Human Genetics. (pp. 149). [Abstract]

Benjes, S. M., Walker, L. C., Aitchison, A., Ganly, P. S., Spearing, R. L., & Morris, C. M. (2006). DNA sequence features of additional partner chromosome-BCR junction fragments associated with complex BCR-ABL_I rearrangements of CML. Proceedings of the 11th International Congress of Human Genetics. Retrieved from http://www.ichg2006.com/abstract/788.htm

Gough, S. M., Ganly, P., Spearing, R., & Morris, C. M. (2006). Hs.500667 and DNTT (TdT): 'Partners in crime' in a novel t(5;10) translocation in ALL. Proceedings of the American Association for Cancer Research (AACR) 97th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/

Conference Contribution - Poster Presentation (not in published proceedings)

Gough, S. M., Ganly, P., Spearing, R., & Morris, C. M. (2006, August-September). Hs.568769 and DNTT (TdT): 'Partners in crime' in a novel t(5;10) translocation in ALL. Poster session presented at the 16th Annual Queenstown Molecular Biology Meeting, Queenstown, New Zealand.

2005

Journal - Research Article

Chambers, S. T., Sanders, J., Patton, W. N., Ganly, P., Birch, M., Crump, J. A., & Spearing, R. L. (2005). Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: Results from a prospective randomized controlled trial. Journal of Hospital Infection, 61, 53-61.

Conference Contribution - Published proceedings: Abstract

Benjes, S. M., Walker, L. C., Ganly, P. S., Spearing, R. L., & Morris, C. M. (2005). Molecular analysis of complex BCR-ABL1 gene rearrangements in chronic myeloid leukaemia. European Journal of Human Genetics, 13(Suppl. 1), (pp. 212-213). [Abstract]

Gough, S., Benjes, S., Spearing, R., Ganly, P., & Morris, C. (2005). Disruption of a lymphocyte development gene cluster at 10q24 by a novel t(5;10) translocation in acute lymphoblastic leukaemia. Chromosome Research: 5th European Cytogenetics Conference. 13(Suppl.1), (pp. 165). [Abstract]

Taylor, K., Ganly, P., Charu, V., DiBenedetto, J., Kracht, K., Rossi, G., & Hernandez, E. (2005). Randomized, double-blind, placebo-controlled study of darbepoetin alfa every 3 weeks for the treatment of chemotherapy-induced anemia. Blood. 106(11), (pp. 992a-993a). [Abstract]

Benjes, S. M., Walker, L. C., Ganly, P. S., Spearing, R. L., & Morris, C. M. (2005). Complex BCR-ABL1 gene rearrangements in chronic myeloid leukemia. Proceedings of the American Association for Cancer Research (AACR) 96th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/

Conference Contribution - Poster Presentation (not in published proceedings)

Fernyhough, L., Ebbett, A., Sanders, J., Spearing, R., Gibbons, S., Ganly, P., … Patton, N. (2005, October). Tandem high dose melphalan (HDM) and HLA identical-sibling allogeneic non myeloablative stem cell transplant (NMAT SCT) for multiple myeloma: A single centre experience. Poster session presented at the HSANZ/ANZSBT/ASTH Annual Scientific Meeting, Sydney, Australia.

Gough, S. M., Benjes, S. M., Spearing, R., Ganly, P., & Morris, C. M. (2005, February). Disruption of a lymphocyte development gene cluster at 10Q24 by a novel T(5;10) translocation in acute lymphoblastic leukaemia. Poster session presented at the International Workshop on Encoding Information in DNA Sequences, Okinawa, Japan.

2004

Journal - Research Article

Ganly, P. S., Walker, L. C., & Morris, C. M. (2004). Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia. Leukemia & Lymphoma, 45(1), 1-10.

Ganly, P., McDonald, M., Spearing, R., & Morris, C. M. (2004). Constitutional t(5;7)(q11;p15) rearranged to acquire monosomy 7q and trisomy 1q in a patient with myelodysplastic syndrome transforming to acute myelocytic leukemia. Cancer Genetics & Cytogenetics, 149(2), 125-130.

Conference Contribution - Published proceedings: Abstract

Gough, S. M., Benjes, S. M., Spearing, R., Ganly, P., & Morris, C. (2004). Disruption of a lymphocyte development gene cluster at 10q24 by a novel t(5;10) translocation in acute lymphoblastic leukaemia (ALL). Proceedings of the HSANZ/ANZSBT/ASTH Annual Scientific Meeting. (P73), (pp. 262). [Abstract]

Benjes, S. M., Walker, L. C., Ganly, P. S., Spearing, R. L., & Morris, C. M. (2004). Complex gene rearrangements in human leukaemia. Proceedings of the Canterbury Health Science Research Conference. (pp. 4). Christchurch: Christchurch School of Medicine and Health Sciences. [Abstract]

Gough, S. M., Benjes, S. M., Spearing, R., Ganly, P., & Morris, C. M. (2004). Disruption of a lymphocyte development gene cluster at 10q24 by a novel t(5;10) translocation in acute lymphoblastic leukaemia (ALL). Proceedings of the Canterbury Health Science Research Conference. (pp. 14). [Abstract]

Moon, S. Y., Ganly, P., Walker, L., Benjes, S., McDonald, M., McKenzie, G., & Morris, C. (2004). High throughput detection of genetic alterations in chronic lymphocytic leukaemia using array comparative genomic hybridisation. Proceedings of the New Zealand Society for Oncology Conference. (pp. 51). [Abstract]

Gough, S. M., Benjes, S., Markie, D., Heaton, D., Spearing, R., Ganly, P., & Morris, C. M. (2004). Dangerous liaison? A novel T(5;10) translocation in acute lymphoblastic leukaemia. Proceedings of the New Zealand Society for Oncology Conference. (pp. 47). [Abstract]

Morris, C., Benjes, S., Gough, S., McDonald, M., McKenzie, G., Moon, S. Y., Walker, L., Morrin, H., … Atkinson, C., Ganly, P., Harris, G., Miller, A., Robinson, B., & Spearing, R. (2004). Cancer genetics: Ar'ray for the future! Proceedings of the New Zealand Society for Oncology Conference. (pp. 30). [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Morris, C., Benjes, S., Gough, S., McDonald, M., McKenzie, G., Moon, S. Y., Walker, L., Morrin, H., … Atkinson, C., Ganly, P., Harris, G., Miller, A. P., Robinson, B., & Spearing, R. (2004, June). Cancer genetics: Ar'ray for the future! Verbal presentation at the New Zealand Society for Oncology Conference, Christchurch, New Zealand.

2003

Conference Contribution - Published proceedings: Abstract

Gough, S. M., Benjes, S., Markie, D. M., Heaton, D., Ganly, P. S., & Morris, C. M. (2003). Molecular analysis of a novel t(5;10) translocation in a case of acute lymphoblastic leukaemia. Proceedings of the Haematology Society of Australia and New Zealand, Australian and New Zealand Society of Blood Transfusion and the Australasian Society of Thrombosis and Haemostasis Annual Scientific Meeting. (pp. 92). Christchurch: HSANZ. [Abstract]

Ganly, P. S., Walker, L. C., & Morris, C. M. (2003). Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia. Proceedings of the Haematology Society of Australia and New Zealand, Australian and New Zealand Society of Blood Transfusion and the Australasian Society of Thrombosis and Haemostasis Annual Scientific Meeting. (pp. 95). Christchurch: HSANZ. [Abstract]

Conference Contribution - Poster Presentation (not in published proceedings)

Chambers, S., Sanders, J., Patton, W. N., Ganly, P. S., Birch, M., Crump, J., & Spearing, R. L. (2003). Reduction of intravascular catheter exit site infections among neutropenic patients by sustained release chlorhexidine dressings: Results from a prospective randomized controlled trial. Poster session presented at the Haematology Society of Australia and New Zealand Annual Scientific Meeting 2003, Christchurch, New Zealand.

Scotter, J. M., Patton, W. N., Campbell, P., Anderson, T. P., Murdoch, D. R., Jennings, L. C., Chambers, S., Ganly, P. S., & Spearing, R. L. (2003, October). Comparison of PCR v galactomannan for the diagnosis of invasive aspergillosis. Poster session presented at the Haematology Society of Australia and New Zealand Annual Scientific Meeting 2003, Christchurch.

2002

Journal - Research Article

Carradice, D., Austin, N., Bayston, K., & Ganly, P. S. (2002). Successful treatment of acute promyelocytic leukaemia during pregnancy. Clinical & Laboratory Haematology, 24, 307-311.

Walker, L. C., Campbell, H. J., Corbett, R., Spearing, R. L., Heaton, D. C., Macdonald, D. H., Morris, C. M., & Ganly, P. S. (2002). A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia. British Journal of Haematology, 117(4), 878-881. doi: 10.1046/j.1365-2141.2002.03512.x

Mullin, J. L., Brennan, S., Ganly, P. S., & George, P. M. (2002). Fibrinogen Hillsborough: A Novel γ309Gly→ Asp Dysfibrinogen. Blood, 99, 3597-3610.

Conference Contribution - Published proceedings: Abstract

Gough, S. M., Markie, D. M., Heaton, D. C., Ganly, P. S., Spearing, R. L., & Morris, C. M. (2002). Dangerous liaison? Molecular analysis of a novel t(5:10) translocation in a case of acute lymphoblastic leukaemia. Proceedings of the American Association for Cancer Research. 43, (pp. 294). San Francisco, CA: American Association for Cancer Research. [Abstract]

2001

Journal - Research Article

Jackson, G., Taylor, P., Smith, G. M., Marcus, R., Smith, A., Chu, P., … Ganly, P. S., … Wilson, M. P. (2001). A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine abd granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation. British Journal of Haematology, 112(1), , 127-137. doi: 10.1046/j.1365-2141.2001.02551.x

Whittle, A. T., Davis, M., Shovlin, C. L., Ganly, P. S., Haslett, C., & Greening, A. P. (2001). Alveolar macrophage activity and the pulmonary complications of haematopoietic stem cell transplantation. Thorax, 56, 941-946.

Ganly, P. S., & Beard, M. (2001). Osteoclasts in Paget's disease of bone. British Journal of Haematology, 113, 259.

Conference Contribution - Published proceedings: Abstract

Ganly, P. S., Heaton, D., Corbett, R., Stevens, J. M., & et al (2001). Identification of a further familial mutation of AML1: Its effects on thrombopoiesis and recovery from chemotherapy and autologous transplant. Blood. 98, (pp. 567A). [Abstract]

Conference Contribution - Poster Presentation (not in published proceedings)

Ganly, P. S., Heaton, D., Corbett, R., Stevens, J. M., & et al (2001, December). Identification of a further familial mutation of AML1: Its effects on thrombopoiesis and recovery from chemotherapy and autologous transplant. Poster session presented at the 43rd Annual Meeting of the American Society of Haematology, Orlando.

Conference Contribution - Verbal presentation and other Conference outputs

Walker, L., Stevens, J. M., Campbell, H., Corbett, R., Spearing, R., Heaton, D., … Morris, C. M., & Ganly, P. S. (2001, October). An inherited mutation of the transcription factor AML1 causes thrombocytopenia with a predicposition for acute myeloid leukaemia. Verbal presentation at the Annual Congress of Haematological Society of Australia and New Zealand, Brisbane.

2000

Conference Contribution - Poster Presentation (not in published proceedings)

McDonald, M., Ganly, P., Spearing, R., & Morris, C. (2000). FISH and whole chromosome painting unmasks acquired rearrangement of a constitutional chromosome translocation to reveal monosomy 7Q and trisomy 1Q in myelodysplastic syndrome. Poster session presented at the Human Genetics Society of Australasia (HGSA) Annual Scientific Meeting, Wellington.

Ganly, P., McDonald, M., Spearing, R., & Morris, C. M. (2000, July). FISH and whole chromosome painting unmasks acquired rearrangement of a constitutional chromosome translocation to reveal monosomy 7Q and trisomy 1Q in myelodysplastic syndrome. Poster session presented at the Annual Congress of Haematological Society of Australia and New Zealand, Perth.

Conference Contribution - Verbal presentation and other Conference outputs

Patton, W. N., Scotter, J., Anderson, T., Jennings, L., Schousboe, M. I., Chan, W., … Ganly, P. (2000, July). Preliminary evaluation of polymerase chain reaction (PCR) method for the diagnosis of invasive fungal infection. Verbal presentation at the Annual Congress of Haematological Society of Australia and New Zealand, Perth.

1997

Conference Contribution - Published proceedings: Abstract

Dang, R. K. B., Cameron, D., Craig, J., Ford, A., Parker, A., Ganly, P. S., & Leonard, R. C. F. (1997). Mobilising peripheral blood progenitor cells for trnsplantation (PBPCT) in breast cancer. British Journal of Haematology, 97(Suppl.), (pp. 38). [Abstract]